HDA UK Media And Political Bulletin – 13 April 2017

April 2017 Price Concessions
PSNC, 12 April 2017

The Department of Health have granted the following price concessions for April 2017:

Drug Pack size Price concession
Amitriptyline 50mg tablets 28 £3.50
Buspirone 10mg tablets 30 £9.57
Buspirone 5mg tablets 30 £16.50
Dapsone 50mg tablets 28 £46.19
Diamorphine 30mg powder for solution for injection ampoules 5 £16.52
Ethosuximide 250mg/5ml oral solution 200ml £173.00
Exemestane 25mg tablets 30 £11.50
Leflunomide 10mg tablets 30 £7.76
Lorazepam 1mg tablets 28 £6.00
Mirtazapine 15mg tablets 28 £3.00
Mirtazapine 30mg tablets 28 £1.40
Mirtazapine 45mg tablets 28 £3.00
Naratriptan 2.5mg tablets 6 £23.00
Nitrofurantoin 100mg tablets 28 £11.20
Nitrofurantoin 50mg tablets 28 £20.50
Oxazepam 10mg tablets 28 £7.97
Oxazepam 15mg tablets 28 £7.97
Pramipexole 88microgram tablets 30 £8.50
Ropinirole 5mg tablets 84 £165.00
Spironolactone 50mg tablets 28 £5.20
Valsartan 160mg capsules 28 £17.25
Valsartan 40mg capsules 28 £8.95
Valsartan 80mg capsules 28 £11.50
Zolmitriptan 2.5mg orodispersible tablets sugar free 6 £15.22
Zolmitriptan 2.5mg tablets 6 £15.30

No endorsements are required as these prices will automatically be applied to this month’s prescriptions.

When any NCSO or price concession announcements are made, these appear on the Generic Shortages page ( and are emailed to those subscribed to this mailing list.

Losing GSi – MHRA emails are changing
MHRA Blog, Mark Birse, 10 April 2017

The MHRA is removing .gsi from its email addresses, so emails will now come from The new email addresses will be more secure and the new system guards against anyone trying to forge the MHRA’s domain name. The MHRA recommends that email contacts are updated accordingly.

Parliamentary Coverage

There is no Parliamentary Coverage.

Full Coverage

Losing GSi – MHRA emails are changing
MHRA Blog, Mark Birse, 10 April 2017

From 10 April, we are removing .gsi from our email addresses.

Launched in 1996, the Government Secure Intranet (GSi) has been used until now to guarantee the security of emails sent by Government agencies and Arms Length Bodies. Technology has changed a lot since 1996 and the GSi is now being phased out across Government.

What’s changing?

From 10 April 2017 we are removing .gsi from our mhra email addresses.  So will now be

Our new email addresses will be more secure, and the new system will protect against anyone trying to forge our domain name (the @mhra bit) and sending emails that claim to be from MHRA.

What do I need to do?

Update your MHRA email contacts and remove .gsi from our email addresses.  Update any tools that use MHRA email addresses.

Emails sent to email addresses including the .gsi will continue to be forwarded until further notice.

If you have any questions about this change or require more information please contact us on

This change only affects email addresses ending in –all email addresses ending in will remain the same.

HDA UK Media And Political Bulletin – 13 April 2017

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?